Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Geriatric MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study.Mov Disord. 2006; 21: 916-923
- Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's.Parkinsonism Relat Disord. 2019; 64: 220-225
- Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease.J Neurol Neurosurg Psychiatry. 1999; 66: 431-435
- The international classification of sleep disorders: diagnostic and coding manual.3rd edition. American Academy of Sleep Medicine, Darien (IL)2014
- The course of insomnia in Parkinson's disease.Parkinsonism Relat Disord. 2016; 33: 51-57
- Changes in insomnia subtypes in early Parkinson disease.Neurology. 2017; 88: 352-358
- The treatment of sleep disorders in Parkinson's disease: from research to clinical practice.Front Neurol. 2017; 8: 42
- Progressive sleep 'destructuring' in Parkinson's disease. A polysomnographic study in 46 patients.Sleep Med. 2005; 6: 313-318
- Subjectively impaired bed mobility in Parkinson disease affects sleep efficiency.Sleep Med. 2013; 14: 668-674
- Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease.Mov Disord. 2006; 21: 983-988
- Clinical guideline for the evaluation and management of chronic insomnia in adults.J Clin Sleep Med. 2008; 4: 487-504
- Scales to assess sleep impairment in Parkinson's disease: critique and recommendations.Mov Disord. 2010; 25: 2704-2716
- Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbidities.J Clin Sleep Med. 2013; 9: 1131-1137
- Insomnia, sleep quality, and quality of life in mild to moderate Parkinson's disease.Ann Am Thorac Soc. 2017; 14: 412-419
- Rotigotine transdermal patch for the treatment of neuropsychiatric symptoms in Parkinson's disease: a meta-analysis of randomized placebo-controlled trials.J Neurol Sci. 2018; 393: 31-38
- Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study.Sleep Med. 2016; 21: 140-144
- Sleep quality and levodopa intestinal gel infusion in Parkinson's disease: a pilot study.Parkinsons Dis. 2018; 2018: 8691495
- Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.Mov Disord. 2019; 34: 180-198
- The effect of light exposure on insomnia and nocturnal movement in Parkinson's disease: an open label, retrospective, longitudinal study.Sleep Med. 2018; 44: 24-31
- Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease.Arch Neurol. 2002; 59: 986-989
- Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study.J Neurol Neurosurg Psychiatry. 2017; 88: 953-959
- Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease.J Neurol Neurosurg Psychiatry. 2017; 88: 653-662
- Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson's disease.J Neurol. 2019; 266: 636-641
- Staging of brain pathology related to sporadic Parkinson's disease.Neurobiol Aging. 2003; 24: 197-211
- Sleep attacks in patients with Parkinson's disease on dopaminergic medications: a systematic review.Movement Disord Clin Pract. 2014; 1: 307-316
- Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard.J Sleep Res. 2000; 9: 5-11
- Clinical predictors of excessive daytime sleepiness in patients with Parkinson's disease.J Clin Neurol (Seoul, Korea). 2018; 14: 530-536
- Clinical features and correlates of excessive daytime sleepiness in Parkinson's disease.Front Neurol. 2019; 10: 121
- Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea.Sleep. 2014; 37: 177-185
- Change in cognition and other non-motor symptoms with obstructive sleep apnea treatment in Parkinson disease.J Clin Sleep Med. 2018; 14: 819-828
- Timed light therapy for sleep and daytime sleepiness associated with Parkinson disease: a randomized clinical trial.JAMA Neurol. 2017; 74: 411-418
- Sodium oxybate for excessive daytime sleepiness and sleep disturbance in Parkinson disease: a randomized clinical trial.JAMA Neurol. 2018; 75: 114-118
- Observations on sleep-disordered breathing in idiopathic Parkinson's disease.PLoS One. 2014; 9: e100828
- Observational study of the relation between Parkinson's disease and sleep apnea.J Parkinsons Dis. 2015; 5: 805-811
- The interaction between obstructive sleep apnea and Parkinson's disease: possible mechanisms and Implications for cognitive function.Parkinsons Dis. 2015; 2015: 849472
- Effect of three hypopnea scoring criteria on OSA prevalence and associated comorbidities in the general population.J Clin Sleep Med. 2019; 15: 183-194
- Obstructive sleep apnoea syndrome.Nat Rev Dis Primers. 2015; 1: 15015
- No increased risk of obstructive sleep apnea in Parkinson's disease.Mov Disord. 2010; 25: 2246-2249
- Laryngopharyngeal motor dysfunction and obstructive sleep apnea in Parkinson's disease.Sleep Breath. 2019; 23: 543-550
- Obstructive sleep apnea in Parkinson's disease patients: effect of Sinemet CR taken at bedtime.Sleep Breath. 2016; 20: 205-212
- Levodopa reverse stridor and prevent subsequent endotracheal intubation in Parkinson disease patients with bilateral vocal cord palsy: a case report.Medicine (Baltimore). 2016; 95: e5559
- Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American academy of sleep medicine clinical practice guideline.J Clin Sleep Med. 2017; 13: 479-504
- Diagnosis of obstructive sleep apnea in Parkinson's disease patients: is unattended portable monitoring a suitable tool?.Parkinsons Dis. 2015; 2015: 258418
- Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea.Neurology. 2017; 88: 1120-1128
- Effect of rapid eye movement sleep behavior disorder on obstructive sleep apnea severity and cognition of Parkinson's disease patients.Chin Med J (Engl). 2018; 131: 899-906
- Prevalence of restless legs syndrome in Parkinson's disease: a systematic review and meta-analysis of observational studies.Sleep Med. 2018; 43: 40-46
- Association of restless legs syndrome with incident Parkinson's disease.Sleep. 2017; 40
- Factors contributing to the development of restless legs syndrome in patients with Parkinson disease.Mov Disord. 2009; 24: 579-582
- A study of the prevalence of restless legs syndrome in previously untreated Parkinson's disease patients: absence of co-morbid association.J Neurol Sci. 2011; 310: 286-288
- A four-year longitudinal study on restless legs syndrome in Parkinson disease.Sleep. 2016; 39: 405-412
- Restless legs syndrome in patients with Parkinson's disease: a comparative study on prevalence, clinical characteristics, quality of life and nutritional status.Acta Neurol Scand. 2015; 131: 211-218
- Restless legs syndrome and Parkinson disease: a causal relationship between the two disorders?.Front Neurol. 2018; 9: 551
- Association between restless legs syndrome and other movement disorders.Neurology. 2019; 92: 948-964
- Disturbances of sleep and alertness in Parkinson's disease.Curr Neurol Neurosci Rep. 2018; 18: 29
- Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.Sleep Med. 2016; 21: 1-11
- Restless legs syndrome and periodic leg movements in patients with movement disorders: specific considerations.Mov Disord. 2017; 32: 669-681
- Efficacy and safety of pramipexole in Chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial.Sleep Med. 2012; 13: 58-63
- Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study.Sleep Med. 2010; 11: 848-856
- Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.Mov Disord. 2004; 19: 1414-1423
- Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.Clin Neuropharmacol. 2009; 32: 311-320
- Comparison of pregabalin with pramipexole for restless legs syndrome.N Engl J Med. 2014; 370: 621-631
- Practice guideline summary: treatment of restless legs syndrome in adults: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology.Neurology. 2016; 87: 2585-2593
- Effects of STN DBS for Parkinson's disease on restless legs syndrome and other sleep-related measures.Parkinsonism Relat Disord. 2011; 17: 208-211
- Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.Neurology. 2018; 91: e1013-e1021
- Diurnal motor variations to repeated doses of levodopa in Parkinson's disease.Clin Neuropharmacol. 2000; 23: 28-33
- Circadian rhythm of rest activity and autonomic nervous system activity at different stages in Parkinson's disease.Auton Neurosci. 2011; 165: 195-200
- Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease.Sleep Med. 2014; 15: 342-347
- Enlightened PD: a novel treatment for Parkinson disease?.Neurology. 2019; 92: 499-500
- Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study.Chronobiol Int. 2007; 24: 521-537
- Chronotherapies for Parkinson's disease.Prog Neurobiol. 2019; 174: 16-27
- Meta-analysis on the prevalence of REM sleep behavior disorder symptoms in Parkinson's disease.BMC Neurol. 2017; 17: 23
- Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort.Neurology. 2013; 81: 1226-1234
- Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study.Brain. 2019; 142: 744-759
- Advances in markers of prodromal Parkinson disease.Nat Rev Neurol. 2016; 12: 622-634
- REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.Neurology. 2010; 75: 494-499
- Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease.Brain. 2007; 130: 2770-2788
- The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument.Mov Disord. 2007; 22: 2386-2393
- Diagnostic accuracy of REM sleep behaviour disorder screening questionnaire: a meta-analysis.Neurol Sci. 2017; 38: 1039-1046
- REM sleep behavior disorder portends poor prognosis in Parkinson's disease: a systematic review.J Clin Neurosci. 2018; 47: 6-13
- REM sleep behavior disorder: diagnosis, clinical implications, and future directions.Mayo Clin Proc. 2017; 92: 1723-1736
- Idiopathic REM sleep behavior disorder and neurodegenerative risk: to tell or not to tell to the patient? How to minimize the risk?.Sleep Med Rev. 2017; 36: 82-95
- REM sleep behaviour disorder.Nat Rev Dis Primers. 2018; 4: 19
- Update on the pharmacology of REM sleep behavior disorder.Neurology. 2006; 67: 742-747
- Best practice guide for the treatment of REM sleep behavior disorder (RBD).J Clin Sleep Med. 2010; 6: 85-95
- Treatment outcomes in REM sleep behavior disorder.Sleep Med. 2013; 14: 237-242
Article info
Publication history
Published online: October 17, 2019
Footnotes
Disclosure: The authors have nothing to disclose.
Conflicts of Interests: The authors declare that they have no conflicts of interest.
Funding: The authors acknowledge research support from NIH/NINDS. Grant number: R01NS099055.
Identification
Copyright
© 2019 Elsevier Inc. All rights reserved.
